Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Microbiological and antimicrobial resistance profiles of shoulder, hip and knee periprosthetic joint infections: a 5-year retrospective single-centre cohort study.

Created on 21 Nov 2026

Authors

Lucas Emil Jørgensen Østergaard, Thomas Greve, Jonas Eeg Madsen, Christen Ravn, Mats Bue

Published in

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. Nov 20, 2026. Epub Nov 20, 2026.

Abstract

Periprost​hetic joint infection (PJI) is a serious complication of arthroplasty, and rising antimicrobial resistance complicates its management. We retrospectively characterised pathogens and resistance profiles of shoulder, hip, and knee PJIs within a five-year single-centre cohort.
We included microbiologically confirmed shoulder, hip, and knee PJIs between June 2020 and March 2025, defined as: (i) at least two samples from tissue or tissue and synovial fluid positive for the same microorganism; or (ii) a single positive synovial fluid culture with a PJI-related diagnostic or surgical procedure code.
We identified 239 PJI episodes in 200 patients, yielding 278 isolates; 208 episodes (87%, n = 208/239) were monomicrobial. Gram-positive bacteria predominated (88%, n = 244/278): Staphylococcus aureus and coagulase-negative staphylococci (CoNS) comprised 53% (n = 146/278) and were the leading pathogens in hip and knee PJIs, whereas Cutibacterium acnes comprised 59% (n = 44/74) of shoulder isolates. Gram-negative and anaerobic bacteria (12%, n = 32/278) were almost exclusively isolated from lower-extremity PJIs. No methicillin-resistant S. aureus was identified, but methicillin-resistant CoNS was common, particularly in knee PJIs. Conventional Danish empirical regimens (cefuroxime, cloxacillin) covered < 70% of hip and knee PJIs and ~ 80% of shoulder PJIs. For lower-extremity PJIs, only vancomycin-containing regimens combined with ciprofloxacin, piperacillin/tazobactam, or meropenem exceeded 90% theoretical coverage. For shoulder PJIs, all vancomycin regimens, including combinations with beta-lactams, achieved this threshold.
PJI microbiology and resistance varied by joint, suggesting joint-specific empirical strategies. Danish beta-lactam regimens provided limited theoretical coverage, particularly for lower-extremity PJIs, driven by methicillin-resistant CoNS. Although clinical validation is needed, the findings support the value of local microbiological surveillance.

PMID:
43062551
Bibliographic data and abstract were imported from PubMed on 21 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement